نتایج جستجو برای: tumor burden

تعداد نتایج: 524097  

Journal: :Current opinion in supportive and palliative care 2016
Giorgio Gandaglia Nicola Fossati Paolo Dell'Oglio Marco Moschini Vito Cucchiara Nazareno Suardi Alexandre Mottrie Vincenzo Mirone Francesco Montorsi Alberto Briganti

PURPOSE OF REVIEW To evaluate the rationale supporting the role of local treatment in the management of patients with metastatic prostate cancer (PCa). RECENT FINDINGS Not all patients with metastatic PCa share the same prognosis, in which selected individuals with oligometastatic PCa might benefit from local therapies. These men would harbor a biologically different disease as compared with ...

Journal: :Blood 2009
David Daydé David Ternant Marc Ohresser Stéphanie Lerondel Sabrina Pesnel Hervé Watier Alain Le Pape Pierre Bardos Gilles Paintaud Guillaume Cartron

Clinical studies have shown a large interindividual variability in rituximab exposure and its significant influence on clinical response in patients receiving similar doses of antibody. The aim of this study was to evaluate the influence of tumor burden on dose-concentration-response relationships of rituximab. Murine lymphoma cells (EL4, 8 x 10(3)), transduced with human CD20 cDNA and transfec...

Journal: :American journal of clinical pathology 2014
Bryce P Portier Rashmi Kanagal-Shamanna Rajyalakshmi Luthra Rajesh Singh Mark J Routbort Brian Handal Neelima Reddy Bedia A Barkoh Zhuang Zuo L Jeffrey Medeiros Kenneth Aldape Keyur P Patel

OBJECTIVES Identification of tumor-specific somatic mutations has had a significant impact on both disease diagnosis and therapy selection. The ability of next-generation sequencing (NGS) to provide a quantitative assessment of mutant allele burden, in numerous target genes in a single assay, provides a significant advantage over conventional qualitative genotyping platforms. METHODS We asses...

Journal: :Cancer research 2006
Seok-Chul Yang Raj K Batra Sven Hillinger Karen L Reckamp Robert M Strieter Steven M Dubinett Sherven Sharma

The antitumor efficiency of dendritic cells transduced with an adenovirus vector expressing secondary lymphoid chemokine (CCL21) was evaluated in a murine model of spontaneous bronchoalveolar cell carcinoma. The transgenic mice (CC-10 TAg) express the SV40 large T antigen (TAg) under the Clara cell promoter, develop bilateral, multifocal, and pulmonary adenocarcinomas, and die at 4 months as a ...

Journal: :Histology and histopathology 2002
K C A Chan Y M D Lo

Patients suffering from malignant diseases have been shown to have increased amounts of cell free nucleic acids in their circulation. As genetic and epigenetic alterations are increasingly characterized in different types of tumors, such changes can be used to detect tumor-derived nucleic acids in the circulation. To date, nearly all tumor-associated nucleic acids have been detected in the plas...

Journal: :Neuro-oncology 2012
Courtney A Crane Brian J Ahn Seunggu J Han Andrew T Parsa

In patients with glioma, the tumor microenvironment can significantly impact pro-inflammatory immune cell functions. However, the mechanisms by which this occurs are poorly defined. Because immunosuppressive regulatory T cells (Treg) are over represented in the tumor microenvironment compared with peripheral blood, we hypothesized that the tumor may have an effect on Treg survival, migration, e...

Journal: :Cancer research 1975
J M Yuhas N H Pazmiño E Wagner

The interaction between line 1 carcinomas growing s.c. and their spontaneous (or artificial) metastases has been studied in syngeneic BALB/c mice. In contrast to typical murine tumor systems, concomitant immunity, or the ability of primary tumors to suppress the growth of metastases, develops very slowly in this system, such that the metastases that are shed within the first week of tumor growt...

2015

"There appears to be a direct correlation between tumor burden and serum CgA levels. Rising serum levels of CgA can predeed radiographic evidence of recurrence. . . . .Using serum CgA level above 30 U/ml, one is able to discriminate between disease free patients and those with recurrent metastatic disease with a sensitivity of 92% and specificity of 96%. This is superior to measuring urinary 5-...

Journal: :The Journal of Experimental Medicine 2002
Linh T. Nguyen Alisha R. Elford Kiichi Murakami Kristine M. Garza Stephen P. Schoenberger Bernhard Odermatt Daniel E. Speiser Pamela S. Ohashi

Using a tumor model of spontaneously arising insulinomas expressing a defined tumor-associated antigen, we investigated whether tumor growth promotes cross-presentation and tolerance of tumor-specific T cells. We found that an advanced tumor burden enhanced cross-presentation of tumor-associated antigens to high avidity tumor-specific T cells, inducing T cell proliferation and limited effector ...

Journal: :Investigative ophthalmology & visual science 2007
Fernando Suárez Maria-Elena Jockovich Eleut Hernandez William Feuer Jean-Marie Parel Timothy G Murray

PURPOSE The purpose of this study was to investigate tumor control efficacy of paclitaxel in the treatment of retinal tumors harbored by the LH beta-Tag murine transgenic model of retinoblastoma. METHODS LH beta-Tag-positive mice (n = 5) 10 weeks of age received two 20-microL subconjunctival injections delivered with a 72-hour interval to right eyes only. Paclitaxel was dissolved in 100% dime...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید